Ancora Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5 Hold
500
﹤0.01% 2381
2025
Q4
$0 Hold
500
﹤0.01% 2552
2025
Q3
$0 Buy
+500
New ﹤0.01% 2112

Ancora Advisors's ACUR Position: Q1 2026 in Review

Ancora Advisors held its Acura Pharmaceuticals (ACUR) position steady in Q1 2026 at 500 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

Ancora Advisors first reported a position in ACUR in Q3 2025 and has held it in 3 quarters since. 1 fund tracked by Wall St. Rank holds ACUR as of Q1 2026.

  • Ancora Advisors held 500 shares of Acura Pharmaceuticals worth $5 as of Q1 2026.
  • Ancora Advisors left its Acura Pharmaceuticals share count unchanged in Q1 2026.
  • Acura Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2381 holding.
  • Ancora Advisors first reported a position in Acura Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 1 fund tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.